source
- A-Alpha Bio starts AI antibody data consortium with GSK, BoltzBiopharma's AI engines need more data. And David Younger thinks there's a great business to sell those data to them. Younger's startup, A-Alpha Bio, has spent months studying how protein-designing…Endpoints · 9d ago↗ source
- Tempus to acquire cancer test maker Personalis for $1.5BTempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.BioPharma Dive · 10d ago↗ source
- Tempus to buy cancer test-maker Personalis for $1.5BTempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.BioPharma Dive · 10d ago↗ source